To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)
Clinical trial NCT06888492 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06888492
- Sponsor
- Guangzhou Jiayin Biotech Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2026-04-25
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.